信義光能(00968.HK)續挫7.6%屢創逾七個月低 遭多間大行削目標價
信義光能(00968.HK)遭多間外資行削減目標價,該股七連跌屢創逾七個月低,今早低見10.14元,現造10.24元,續挫7.6%,成交仍達6,865萬股,涉資7.14億元。
大和將信義能目標價下調20.7%至均為11.5元,以反映下調光伏玻璃平均銷售單價預測及調低公司未來三年盈測7%-10%。花旗也降信義光能目標價23%至11.5元,以反映太陽能玻璃售價下降,預計今年3.2mm玻璃價格自每平方米31.29元人民幣降至28元人民幣,另外預測今年2mm玻璃價格將自每平方米28元人民幣降至22元人民幣,明年則料自每平方米22元人民幣降至18元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.